MX2009004553A - Metodos para el tratamiento de trastornos cocleares y vestibulares. - Google Patents
Metodos para el tratamiento de trastornos cocleares y vestibulares.Info
- Publication number
- MX2009004553A MX2009004553A MX2009004553A MX2009004553A MX2009004553A MX 2009004553 A MX2009004553 A MX 2009004553A MX 2009004553 A MX2009004553 A MX 2009004553A MX 2009004553 A MX2009004553 A MX 2009004553A MX 2009004553 A MX2009004553 A MX 2009004553A
- Authority
- MX
- Mexico
- Prior art keywords
- formula
- group
- methods
- phenyl
- alkyl
- Prior art date
Links
- 208000026845 Cochlear disease Diseases 0.000 title 1
- 208000027601 Inner ear disease Diseases 0.000 title 1
- 208000027491 vestibular disease Diseases 0.000 title 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 239000011737 fluorine Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 229910052740 iodine Inorganic materials 0.000 abstract 1
- 239000011630 iodine Substances 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Esta invención está dirigida a métodos para proveer otoprotección, que comprenden administrar a un sujeto que necesita la misma una cantidad terapéuticamente efectiva de un compuesto seleccionado del grupo que consiste de la fórmula (I) y la fórmula (II) (ver fórmulas) o una sal o éster farmacéuticamente aceptable del mismo, en donde fenilo es sustituido en X con uno a cinco átomos de halógeno seleccionandos del grupo que consiste de flúor, cloro, bromo y yodo; y, R1, R2, R3, R4, R5 Y R6 se seleccionan independientemente del grupo que consiste de hidrógeno y alquilo de C1-C4; en donde alquilo de C1-C4 es opcionalmente sustituido con fenilo (en donde fenilo es opcionalmente sustituido con sustituyentes independientemente seleccionados del grupo que consiste de halógeno, alquilo de C1-C4, alcoxi de C1-C4, amino, nitro y ciano).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US86314406P | 2006-10-27 | 2006-10-27 | |
| PCT/US2007/081031 WO2008060787A2 (en) | 2006-10-27 | 2007-10-11 | Methods for treatment of cochlear and vestibular disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009004553A true MX2009004553A (es) | 2009-11-10 |
Family
ID=39402353
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009004553A MX2009004553A (es) | 2006-10-27 | 2007-10-11 | Metodos para el tratamiento de trastornos cocleares y vestibulares. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20080103198A1 (es) |
| EP (1) | EP2079465A2 (es) |
| JP (1) | JP2010523468A (es) |
| KR (1) | KR20090085071A (es) |
| CN (1) | CN101568335A (es) |
| AU (1) | AU2007319578A1 (es) |
| BR (1) | BRPI0718316A2 (es) |
| CA (1) | CA2667587A1 (es) |
| CO (1) | CO6180505A2 (es) |
| CR (1) | CR10830A (es) |
| EA (1) | EA200970424A1 (es) |
| IL (1) | IL198395A0 (es) |
| MX (1) | MX2009004553A (es) |
| NO (1) | NO20091658L (es) |
| WO (1) | WO2008060787A2 (es) |
| ZA (1) | ZA200903653B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9018253B2 (en) | 2010-07-02 | 2015-04-28 | Bio-Pharm Solutions Co., Ltd. | Phenylcarbamate compound and muscle relaxant containing the same |
| US8609849B1 (en) | 2010-11-30 | 2013-12-17 | Fox Chase Chemical Diversity Center, Inc. | Hydroxylated sulfamides exhibiting neuroprotective action and their method of use |
| WO2012096458A2 (en) | 2011-01-13 | 2012-07-19 | Bio-Pharm Solutions Co., Ltd. | Process for preparation of phenyl carbamate derivatives |
| RU2475223C1 (ru) * | 2011-07-06 | 2013-02-20 | Государственное образовательное учреждение высшего профессионального образования "Самарский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации | Способ лечения кохлео-вестибулярных расстройств у пациентов с остеохондрозом шейного отдела позвоночника |
| CN104870421A (zh) | 2011-12-27 | 2015-08-26 | 比皮艾思药物研发有限公司 | 用于预防或治疗als的苯基氨基甲酸酯化合物 |
| KR101717872B1 (ko) | 2013-03-12 | 2017-03-17 | (주)바이오팜솔루션즈 | 소아 간질 및 간질-관련 증후군의 예방 또는 치료용 페닐카바메이트 화합물 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3313692A (en) * | 1958-04-21 | 1967-04-11 | Armour Pharma | Method of inducing calming and muscle relaxation with carbamates |
| US3265728A (en) * | 1962-07-18 | 1966-08-09 | Armour Pharma | Substituted phenethyl carbamates |
| US5698588A (en) * | 1996-01-16 | 1997-12-16 | Yukong Limited | Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol |
| GB0024517D0 (en) * | 2000-10-06 | 2000-11-22 | Glaxo Group Ltd | Use of medicaments |
| SE0100344D0 (sv) * | 2001-02-05 | 2001-02-05 | Jan Nordmark | New Use |
-
2007
- 2007-10-11 KR KR1020097010733A patent/KR20090085071A/ko not_active Application Discontinuation
- 2007-10-11 JP JP2009534755A patent/JP2010523468A/ja active Pending
- 2007-10-11 BR BRPI0718316-0A patent/BRPI0718316A2/pt not_active IP Right Cessation
- 2007-10-11 US US11/870,511 patent/US20080103198A1/en not_active Abandoned
- 2007-10-11 CA CA002667587A patent/CA2667587A1/en not_active Abandoned
- 2007-10-11 MX MX2009004553A patent/MX2009004553A/es unknown
- 2007-10-11 AU AU2007319578A patent/AU2007319578A1/en not_active Abandoned
- 2007-10-11 WO PCT/US2007/081031 patent/WO2008060787A2/en active Application Filing
- 2007-10-11 CN CNA2007800483062A patent/CN101568335A/zh active Pending
- 2007-10-11 EP EP07868417A patent/EP2079465A2/en not_active Withdrawn
- 2007-10-11 EA EA200970424A patent/EA200970424A1/ru unknown
-
2009
- 2009-04-26 IL IL198395A patent/IL198395A0/en unknown
- 2009-04-27 NO NO20091658A patent/NO20091658L/no not_active Application Discontinuation
- 2009-04-30 CO CO09043789A patent/CO6180505A2/es not_active Application Discontinuation
- 2009-05-26 ZA ZA200903653A patent/ZA200903653B/xx unknown
- 2009-05-27 CR CR10830A patent/CR10830A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008060787A3 (en) | 2008-08-28 |
| JP2010523468A (ja) | 2010-07-15 |
| ZA200903653B (en) | 2010-08-25 |
| IL198395A0 (en) | 2010-02-17 |
| WO2008060787A2 (en) | 2008-05-22 |
| AU2007319578A1 (en) | 2008-05-22 |
| CR10830A (es) | 2009-09-29 |
| NO20091658L (no) | 2009-05-25 |
| BRPI0718316A2 (pt) | 2014-07-01 |
| CA2667587A1 (en) | 2008-05-22 |
| EA200970424A1 (ru) | 2010-04-30 |
| KR20090085071A (ko) | 2009-08-06 |
| CN101568335A (zh) | 2009-10-28 |
| EP2079465A2 (en) | 2009-07-22 |
| CO6180505A2 (es) | 2010-07-19 |
| US20080103198A1 (en) | 2008-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20071921L (no) | Fremgangsmater for behandling av epileptogenese og epilepsi | |
| WO2007008562A3 (en) | Carbamate compounds for use in treating neurodegenerative disorders | |
| TW200744575A (en) | Methods of treating epileptogenesis | |
| IL189003A0 (en) | Methods for treating substance-related disorders | |
| TW200637540A (en) | Methods for QT interval control | |
| MY138156A (en) | Carbamate compounds for use in preventing or treating neurodegenerative disorders | |
| MX2009004553A (es) | Metodos para el tratamiento de trastornos cocleares y vestibulares. | |
| YU67703A (sh) | Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju poremećaja kretanja | |
| RS67603A (en) | Carbamate compounds for use in the treatment of pain | |
| IL157590A0 (en) | Carbamate compounds for use in preventing or treating bipolar disorder | |
| EA200700871A1 (ru) | Способы нейропротекции | |
| HK1062270A1 (en) | Carbamate compounds for use in preventing or treating anxiety disorders | |
| RS67503A (en) | Carbamate compounds for use in preventing of treating psychotic disorders | |
| TW200701978A (en) | Methods of treating epileptogenesis and epilepsy | |
| HK1063435A1 (en) | Carbamate compounds for use in preventing or treating neuropathic pain | |
| MY136733A (en) | Carbamate compounds for use in preventing or treating psychotic disorders | |
| MY149385A (en) | Methods for treating substance-related disorders | |
| CY1110672T1 (el) | Χρηση των 2- φαινυλ-1,2-αιθανοδιολης- (δι) καρβαμικων για θεραπεια επιληπτογενεσης |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HH | Correction or change in general |